OVERALL PIPELINES
Cellatoz Therapeutics, Inc. has developed its proprietary and unique cells with distinctive characteristics and potentials of therapeutic agents as RMAT (Regenerative Medicine Advanced Therapy) products meeting the unmet medical needs. Based on our successful experiences of R&D and commercialization of cell therapies, we promise to become a leading global biotech company in the research and development of cell therapy.
PIPELINES
| Project | Discovery | Preclinical | Phase 1 | Phase 2 | |
|---|---|---|---|---|---|
CLZ-1001 / ES-MSSC (Embryonic stem cell-derived | Regeneration of knee/ankle cartilages | ||||
Regeneration of fractured bones w/ osteoporosis | |||||
Regeneration of Periodontium for dental implants | |||||
CLZ-2002 / T-SC (tonsil MSC-derived Schwann Cell) | CMT (Charcot-Marie-Tooth) disease | ||||
carpal tunnel syndrome | |||||
Acute / chronic spinal cord injury by accident | |||||
CLZ-3001 / NK cell | Non-small cell lung cancer (NSCLC) | ||||
ovarian cancer | |||||
breast cancer |
CLZ-1001 |
|||
Regeneration of knee/ankle cartilages |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
Regeneration of fractured bones w/ osteoporosis |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
Regeneration of Periodontium for dental implants |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
CLZ-2002 |
|||
CMT (Charcot-Marie-Tooth) disease |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
carpal tunnel syndrome |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
Acute / chronic spinal cord injury by accident |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
CLZ-3001 |
|||
Non-small cell lung cancer (NSCLC) |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
ovarian cancer |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
breast cancer |
|||
| Discovery | Preclinical | Phase 1 | Phase 2 |
Allogenic Autologous
